NCT02089256View on ClinicalTrials.gov

Effect of Repeated Administration of Liraglutide on Insulinogenic Indices

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Healthy
Interventions
DRUG

Liraglutide

"Graded glucose infusion test (GGIT)will be performed on baseline. 1 week later treatment with liraglutide 0.6mg/day (injected between 21.00-23.00) will be initiated.~GGIT will be repeated 12 hours after first injection and after 21 days on-treatment (12 hours after last injection)."

Trial Locations (1)

Unknown

Tartu University Hospital, Tartu

All Listed Sponsors
lead

University of Tartu

OTHER

NCT02089256 - Effect of Repeated Administration of Liraglutide on Insulinogenic Indices | Biotech Hunter | Biotech Hunter